Newer -omics techniques: Focus on the usefulness of genomics and metabolomics study.

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Presentation
  • By: TOHKIN, Masahiro (Graduate School of Pharmaceutical Sciences, Nagoya City University, Regulatory Science, Nagoya, Japan)
  • Co-author(s): Masahiro Tohkin
  • Abstract:

    I would like to talk about the pharmacogenomics and metabolomics approach to find the biomarker of severe adverse drug reaction, such as Stevens-Johnson syndrome. We conducted the Genome Wide Association Study (GWAS) analysis of the genome from the patients of Allopurinol-dependent Stevens-Johnson syndrome, and we found the Single Nucleotide

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login